首页> 外文期刊>Pancreas >Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors A Retrospective Nationwide Multicenter Study in South Korea
【24h】

Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors A Retrospective Nationwide Multicenter Study in South Korea

机译:美国癌症和欧洲神经内分泌肿瘤联合委员会对胰腺神经内分泌肿瘤分期分类的预后有效性在韩国的一项全国性多中心回顾性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: Pancreatic neuroendocrine tumors (pNETs) are diverse diseases with different prognosis. The American Joint Committee on Cancer (AJCC) and the European Neuroendocrine Tumor Society (ENETS) introduced 2 different tumor node metastasis (TNM) stages, and the World Health Organization (WHO) proposed WHO 2010 grading system for pNETs. Therefore, we aimed to validate the prognostic relevance of these 3 systems for pNETs in South Korea.
机译:目的:胰腺神经内分泌肿瘤(pNETs)是多种预后不同的疾病。美国癌症联合委员会(AJCC)和欧洲神经内分泌肿瘤学会(ENETS)引入了两个不同的肿瘤结转移(TNM)阶段,世界卫生组织(WHO)提出了WHO 2010年pNETs分级系统。因此,我们旨在验证这3种系统对韩国pNET的预后相关性。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号